Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 14, issue 6, 2016

Review of Economic Submissions to NICE Medical Technologies Evaluation Programme pp. 623-634

Abualbishr Alshreef, Michelle Jenks, William Green and Simon Dixon

Parafricta Bootees and Undergarments to Reduce Skin Breakdown in People with or at Risk of Pressure Ulcers: A NICE Medical Technologies Guidance pp. 635-646

Catherine Meads, Matthew Glover, Paul Dimmock and Subhash Pokhrel

Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review pp. 647-657

Carlos K. H. Wong, Brian H. H. Lang, Vivian Y. W. Guo and Cindy L. K. Lam

A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines pp. 659-672

Kittiphong Thiboonboon, Benjarin Santatiwongchai, Varit Chantarastapornchit, Waranya Rattanavipapong and Yot Teerawattananon

India’s Proposed Universal Health Coverage Policy: Evidence for Age Structure Transition Effect and Fiscal Sustainability pp. 673-690

Muttur Ranganathan Narayana

Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany pp. 691-701

Florian Hofer, Dmitrij Achelrod and Tom Stargardt

The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume–Output Effects Matter pp. 703-718

Jonathan P. Goldstein, George M. Babikian, Adam J. Rana, Johanna A. Mackenzie and Andrew Millar

Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands pp. 719-727

Vassilis Fragoulakis, Chris P. Pescott, Jesper M. J. Smeenk, Evert J. P. Santbrink, G. Jur E. Oosterhuis, Frank J. M. Broekmans and Nikos Maniadakis

Comment on: “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review” pp. 729-730

Afschin Gandjour

Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review” pp. 731-732

Suzanne Laplante, Frank X. Liu, Bruce Culleton, Angelito Bernardo, Denise King and Pollyanna Hudson

A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course” pp. 733-734

Ahmed Abdulla and Angela Stainthorpe

Volume 14, issue 5, 2016

Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers? pp. 507-509

Afschin Gandjour

Supporting Medicare Health, Equity and Efficiency in Australia: Policies Undermining Bulk Billing Need to Be Scrapped pp. 511-514

Simon Eckermann and Lynnaire Sheridan

The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance pp. 515-526

Alistair Ray, Helen Morgan, Antony Wilkes, Kimberley Carter and Grace Carolan-Rees

Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review pp. 527-543

Miriam Luhnen, Siw Waffenschmidt, Andreas Gerber-Grote and Gloria Hanke

Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK pp. 545-558

Stephen Montgomery, Jeanette Kusel, Felicity Allen and Nicholas Adlard

A Qualitative Evaluation of Program Budgeting and Marginal Analysis in a Canadian Pediatric Tertiary Care Institution pp. 559-568

Neale Smith, Craig Mitton, Mary-Ann Hiltz, Matthew Campbell, Laura Dowling, J. Fergall Magee and Shashi Ashok Gujar

Barrier to Access or Cost Share? Coinsurance and Dental-Care Utilization in Colombia pp. 569-578

Lucas Higuera Jaramillo and Sergio Prada

Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal pp. 579-594

M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Jean-Bernard Gruenberger, Joao Carrasco, Claudia Pitotti, Elsa Sauvage, Sara Chehab and David Price

Care Appropriateness and Health Productivity Evolution: A Non-Parametric Analysis of the Italian Regional Health Systems pp. 595-607

Paolo Mancuso and Vivian Valdmanis

Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion pp. 609-617

Katherine M. Prioli, Laura T. Pizzi, Julie Katz Karp, Taki Galanis and Jay H. Herman

Volume 14, issue 4, 2016

The Potential Impact of the Trans-Pacific Partnership Agreement on Health Equity, with Illustration From New Zealand pp. 397-400

Gay Keating, Rhys Jones, Erik Monasterio and Josh Freeman

Governments Need Better Guidance to Maximise Value for Money: The Case of Australia’s Pharmaceutical Benefits Advisory Committee pp. 401-407

Drew Carter, Arlene Vogan and Hossein Haji Ali Afzali

Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review pp. 409-418

Adam J. N. Raymakers, John Mayo, Stephen Lam, J. Mark FitzGerald, David G. T. Whitehurst and Larry D. Lynd

Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups pp. 419-429

Huanxue Zhou, Christopher Taber, Steve Arcona and Yunfeng Li

Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses pp. 431-440

Manal H. El-Hamamsy, Gihan H. Elsisi, Randa Eldessouki, Mohamed M. Elmazar, Ahmed S. Taha, Basma F. Awad and Hossam Elmansy

Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany pp. 441-452

I. Aumann, M. Treskova, N. Hagemann and Johann Graf von der Schulenburg

Measuring the Volume-Outcome Relation for Complex Hospital Surgery pp. 453-464

Woohyeon Kim, Stephen Wolff and Vivian Ho

Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain pp. 465-477

Eliazar Sabater, Armando López-Guillermo, Antonio Rueda, Antonio Salar, Itziar Oyagüez and Juan Manuel Collar

The Efficiency of Increasing the Capacity of Physiotherapy Screening Clinics or Traditional Medical Services to Address Unmet Demand in Orthopaedic Outpatients: A Practical Application of Discrete Event Simulation with Dynamic Queuing pp. 479-491

L. Standfield, T. Comans, M. Raymer, S. O’Leary, N. Moretto and Paul Scuffham

A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence pp. 493-505

Philippe Laramée, Aurélie Millier, Nora Rahhali, Olivier Cristeau, Samuel Aballéa, Clément François, Ylana Chalem, Mondher Toumi and Jürgen Rehm

Volume 14, issue 3, 2016

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? pp. 245-252

Mark Jit and Raymond Hutubessy

The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance pp. 267-279

Andrew Cleves, Paul Dimmock, Neil Hewitt and Grace Carolan-Rees

Key Aspects of a Sustainable Health Insurance System in Germany pp. 293-312

Matthias Pelster, Vera Hagemann and Franziska Laporte Uribe

Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation pp. 313-322

Amy Tawfik, Walter P. Wodchis, Petros Pechlivanoglou, Jeffrey Hoch, Don Husereau and Murray Krahn

Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis pp. 323-335

Yuko Saruta and Jaume Puig-Junoy

Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis pp. 337-347

Samer Hamidi and Fevzi Akinci

The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations pp. 349-359

Ali Moghtaderi and Scott Adams

Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making pp. 375-385

Takeru Shiroiwa, Shinya Saito, Kojiro Shimozuma, Satoshi Kodama, Shinichi Noto and Takashi Fukuda

Volume 14, issue 2, 2016

A Review of “The New Drug Reimbursement Game: A Regulator’s Guide to Playing and Winning” pp. 127-128

Christopher J. McCabe

Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance pp. 135-149

Michelle Jenks, Joyce Craig, William Green, Neil Hewitt, Mick Arber and Andrew Sims

A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis pp. 151-159

Ilene L. Hollin and Karen A. Robinson

A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health pp. 161-183

Elizabeth Goodwin and Colin Green

The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review pp. 185-193

S. Laplante, F. X. Liu, B. Culleton, A. Bernardo, Denise King and P. Hudson

Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment pp. 195-204

Sachiko Ozawa, Simrun Grewal and John F.P. Bridges

The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke’s Encephalopathy Presenting at the Emergency Department pp. 205-215

Edward C. F. Wilson, George Stanley and Zulfiquar Mirza

Formal Professional Relationships Between General Practitioners and Specialists in Shared Care: Possible Associations with Patient Health and Pharmacy Costs pp. 217-227

Ágnes Lublóy, Judit Lilla Keresztúri and Gábor Benedek

Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care pp. 229-240

Laura T. Pizzi, Judie Tran, Anousheh Shafa, Michael Waisbourd, Lisa Hark, Ann P. Murchison, Yang Dai, Eileen L. Mayro and Julia A. Haller

Comment on: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011” pp. 241-241

Afschin Gandjour

Authors’ Reply to Gandjour: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011” pp. 243-243

Kenneth E. Thorpe, Lindsay Allen and Peter Joski

Volume 14, issue 1, 2016

Why ‘Optimal’ Payment for Healthcare Providers Can Never be Optimal Under Community Rating pp. 9-20

Peter Zweifel and Harry Frech

Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA pp. 29-40

Axel C. Mühlbacher and Anika Kaczynski

Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation pp. 77-87

Ataru Igarashi, Rei Goto, Kiyomi Suwa, Reiko Yoshikawa, Alexandra J. Ward and Jörgen Moller

Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness pp. 89-104

Donna Rowen, John Brazier, Anju Keetharuth, Aki Tsuchiya and Clara Mukuria

Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists” pp. 117-118

Carl Samuelsen, Eric D. Bateman, Ian Pavord, Adam Lloyd, Mike Baldwin and Dirk Esser

Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists pp. 119-125

Jenny Willson, Eric D. Bateman, Ian Pavord, Adam Lloyd, Tania Krivasi and Dirk Esser